| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $94.2M | — | +42.1% |
| Cost of Revenue | $43.7M | — | +47.5% |
| Gross Profit | $50.4M | — | +37.7% |
| R&D Expense | $33.4M | — | +44.8% |
| SG&A Expense | $29.1M | — | +45.5% |
| Operating Income | -$34.9M | — | -53.2% |
| Pre-tax Income | -$137.9M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $368.1M | +60.4% | +175.8% |
| Accounts Receivable | $61.6M | -26.2% | -17.5% |
| Inventory | $9.3M | +52.7% | — |
| Current Assets | $849.0M | +9.5% | +161.4% |
| Total Assets | $1.25B | +9.2% | +90.1% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.4M | — | -11.0% |
| Capital Expenditures | $17.3M | — | +113.2% |
| Investing Cash Flow | $30.4M | — | +1647.9% |
| Financing Cash Flow | $95.2M | — | +1139.4% |
| Free Cash Flow | -$1.9M | — | -120.3% |
| -1078.3% |
| Income Tax | $1.0M | — | +8.9% |
| Net Income | -$138.9M | — | -999.7% |
| EPS (Basic) | -$0.40 | — | -900.0% |
| EPS (Diluted) | -$0.40 | — | -900.0% |
| $302.5M |
| -35.6% |
| +95.8% |
| Total Liabilities | $807.7M | -15.6% | +278.2% |
| Stockholders' Equity | $443.7M | +135.5% | -0.2% |